EUVIMEDEUVIMED entdecken
Open Access

Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer

Weihua Song, Fuying Chu, Wei Xie, Ping Zhao, Yajun Miao, Xiang Chen

American Journal of Cancer Research · 2026 · 16 (1) · 338-352

DOI: 10.62347/fygp7808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Weihua Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Nantong First People's Hospital Nantong 226001, Jiangsu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Non-small cell lung cancerchemotherapycoagulation biomarkersimmune checkpoint inhibitorsvenous thromboembolism

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Nantong First People's Hospital Nantong 226001, Jiangsu, China.
  • Department of Oncology, Nantong First People's Hospital Nantong 226001, Jiangsu, China.

Zitieren

APA

Song, W., Chu, F., Xie, W., Zhao, P., Miao, Y., & Chen, X. (2026). Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer. American Journal of Cancer Research, 16(1), 338-352. https://doi.org/10.62347/fygp7808

Vancouver

Song W, Chu F, Xie W, Zhao P, Miao Y, Chen X. Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer. American Journal of Cancer Research. 2026;16(1):338-352. doi:10.62347/fygp7808

BibTeX
@article{Song2026,
  author = {Song, Weihua and Chu, Fuying and Xie, Wei and Zhao, Ping and Miao, Yajun and Chen, Xiang},
  title = {Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {338--352},
  doi = {10.62347/fygp7808}
}
Kostenlos starten →